JAMA · 1970 · 57 citations · 7 references
MedicineHematologyPharmacologyHematology PhysiologyHemostasisPharmacodynamicsAnticoagulant TherapyAnticoagulation TherapyAntithrombotic TherapyHemostatic AgentsThrombosisActivated Clotting TimeAssayHeparin AnticoagulationHeparin-mediated AnticoagulationPlasma Anticoagulant ActivityPrecisionResearch With Human SubjectsTherapeutic Anticoagulation
The kinetics of heparin's anticoagulant activity were studied with four assay methods in human subjects, following single intravenous doses within the usual clinical dose range. The half-life of anticoagulant activity was about 1.5 hours. Minimum doses of heparin required to anticoagulate blood to a clinically desirable extent were about 35 units/kg. Of the four tests used, the whole-blood activated partial thromboplastin time provided the greatest precision, information, and economy, followed by, in order, the activated plasma partial thromboplastin time, the whole blood clotting time, and the partial thromboplastin time of plasma.
7
Kinetics of pharmacologic effects
Gerhard Levy · Clinical Pharmacology & Therapeutics · 1966 · 194 citations
Control of Heparin Therapy With Activated Partial Thromboplastin Times
I Spector, Morton Corn · JAMA · 1967 · 50 citations
EFFECTS OF ANTICOAGULANTS ON SERUM AND PLASMA
Hans Hoch, Alfred Chanutin · Journal of Biological Chemistry · 1952 · 28 citations · Full text
Medicine, Hematology, Hemostasis +7